IRIS
PASTORINO, LORENZA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.687
AS - Asia 1.562
NA - Nord America 1.433
Continente sconosciuto - Info sul continente non disponibili 302
SA - Sud America 142
AF - Africa 22
OC - Oceania 12
Totale 17.160
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.424
US - Stati Uniti d'America 1.345
SG - Singapore 572
CN - Cina 397
VN - Vietnam 276
BD - Bangladesh 175
FR - Francia 112
BR - Brasile 77
HK - Hong Kong 42
CA - Canada 36
FI - Finlandia 30
AR - Argentina 29
JP - Giappone 28
DE - Germania 27
CH - Svizzera 17
GB - Regno Unito 17
IN - India 13
AU - Australia 12
NL - Olanda 12
CR - Costa Rica 11
MX - Messico 11
IQ - Iraq 10
CL - Cile 8
CO - Colombia 8
IE - Irlanda 8
ID - Indonesia 7
JM - Giamaica 7
EC - Ecuador 6
GT - Guatemala 5
UZ - Uzbekistan 5
VE - Venezuela 5
AT - Austria 4
CZ - Repubblica Ceca 4
ES - Italia 4
HN - Honduras 4
PL - Polonia 4
RU - Federazione Russa 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
ET - Etiopia 3
JO - Giordania 3
KR - Corea 3
LT - Lituania 3
MA - Marocco 3
OM - Oman 3
PK - Pakistan 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
ZA - Sudafrica 3
AL - Albania 2
AZ - Azerbaigian 2
CY - Cipro 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
MY - Malesia 2
NI - Nicaragua 2
RS - Serbia 2
SA - Arabia Saudita 2
SN - Senegal 2
SV - El Salvador 2
TR - Turchia 2
UA - Ucraina 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
GY - Guiana 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LK - Sri Lanka 1
ME - Montenegro 1
ML - Mali 1
MW - Malawi 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
SE - Svezia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TG - Togo 1
Totale 16.858
Salva come PNG Salva come JPEG
Città #
Genova 7.156
Genoa 3.971
Rapallo 1.151
Vado Ligure 910
San Jose 322
Singapore 243
Ashburn 169
Lauterbourg 104
Beijing 88
Ho Chi Minh City 83
Council Bluffs 76
Hanoi 66
New York 56
Hong Kong 40
Milan 38
Santa Clara 32
Bordighera 27
Helsinki 27
Los Angeles 24
Frankfurt am Main 22
Tokyo 20
Buffalo 15
Dallas 15
Rome 14
Zurich 14
Boardman 13
Chicago 12
São Paulo 12
Haiphong 11
Houston 11
Tianjin 11
Atlanta 10
Da Nang 10
Bologna 9
Charlotte 8
London 8
Miami 8
Naples 8
Phoenix 8
San José 8
Dublin 7
Mexico City 7
Orem 7
Amsterdam 6
Baghdad 6
Montreal 6
Philadelphia 6
Biên Hòa 5
Hải Dương 5
Minneapolis 5
Newark 5
Queens 5
Rio de Janeiro 5
San Antonio 5
The Bronx 5
Brooklyn 4
Buenos Aires 4
Can Tho 4
Catania 4
Columbus 4
Da Lat 4
Denver 4
Des Moines 4
Detroit 4
Guatemala City 4
Kingston 4
Mumbai 4
Ocala 4
Quảng Ngãi 4
Van Nuys 4
Vienna 4
Addis Ababa 3
Alexandria 3
Anchorage 3
Athens 3
Bari 3
Brugherio 3
Bắc Ninh 3
Cartago 3
Clinton 3
Dayton 3
Florence 3
Garland 3
Helena 3
Hưng Yên 3
Jackson 3
Kirkland 3
Lake Worth 3
Lappeenranta 3
Las Vegas 3
Marseille 3
Modena 3
Ninh Bình 3
Palermo 3
Pharr 3
Prague 3
Raleigh 3
Riverside 3
Rudolfstetten 3
San Francisco 3
Totale 15.066
Salva come PNG Salva come JPEG
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 260
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. 246
BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. 236
Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome. 233
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 227
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. 222
Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. 221
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study 220
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 219
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 219
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. 218
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 215
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma 209
MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: A pooled-analysis from the M-SKIP project. 206
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 203
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma 198
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. 197
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip Project 195
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 194
Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients. 192
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 189
A comparison of CDKN2A mutation detection within the Melanoma Genetics Consortium (GenoMEL) 188
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148 187
Brooke-Spiegler syndrome tumor spectrum beyond the skin: a patient carrying germline R936X CYLD mutation and a somatic CYLDmutation in Brenner tumor 186
Gly101Trp germline mutation in the CDKN2A gene in familial and non familial Ligurian melanoma patients 183
Ameloblastoma: a neglected criterion for nevoid basal cell carcinoma (Gorlin) syndrome. 183
ANALISI GENOME-WIDE PER LA SUSCETTIBILITÀ AL MELANOMA: NUOVI LOCICHE CONFERMANO IL RUOLO DEI GENI DELLA PIGMENTAZIONE 180
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 177
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents 176
The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: Impact of novel variants predisposing to melanoma 168
Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 166
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma. 165
Clinical genetic testing for familial melanoma in Italy: a cooperative study. 164
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 163
Genome-wide association study identifies three new melanoma susceptibility loci 163
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history. 160
Novel PTCH1 Mutations in Patients with Keratocystic Odontogenic Tumors Screened for Nevoid Basal Cell Carcinoma (NBCC) Syndrome 159
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 158
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 157
High prevalence of the G101W germline mutation in the CDKN2A (P16INK4A) gene in 62 Italian malignant melanoma families 157
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 157
Nevoid Basal Cell Carcinoma Syndrome in infants: improving diagnosis. 156
"Gestione Melanoma" un "database" relazionale per lo studio e l’approfondimento della relazione genotipo/fenotipo e genotipo/ambiente nel melanoma familiare e sporadico 155
Varianti polimorfiche del gene MC1R (Melanocortin receptor 1) nella popolazione ligure ed associazione con il rischio di melanoma 155
Functional analysis of a CDKN2A 5’UTR germline variant associated with pancreatic cancer development 155
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma 152
Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin 151
Identification of a SUFU germline mutation in a family with Gorlin syndrome 150
A novel PTCH1 gene mutation in a pediatric patient associated multiple keratocystic odontogenic tumors of the jaws and Gorlin-Goltz syndrome 149
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma 148
MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients. 148
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma 145
Hereditary trichilemmal cysts: A proposal for the assessment of diagnostic clinical criteria 145
3’UTR polymorphisms in the CDKN2A gene and age at onset of familial and sporadic melanoma from Liguria 144
Patched homolog 1 gene mutation (p.G1093R) induces nevoid basal cell carcinoma syndrome and non-syndromic keratocystic odontogenic tumors: A case report. 143
Five novel germline function-impairing mutations of CYLD in Italian patients with multiple cylindromas 143
Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma 142
Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma 142
The role of AIRE polymorphisms in melanoma. 141
Analisi molecolare del gene PTCH nella Sindrome di Gorlin (Carcinoma Nevo Basocellulare NBCCS) 136
Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression 136
Novel MC1R variants in Ligurian melanoma patients and controls 135
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations 135
Ink4/ARF germline mutations and additional neoplasia in pancretic cancer patients and their families 134
CDKN2A Unclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment 134
CDKN2A germline mutation analysis in patients with pancreatic adenocarcinoma from Liguria 132
Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome--a new clinical perspective. 131
Multiple rare variants in high-risk pancreatic cancer-related genes may increase risk for pancreatic cancer in a subset of patients with and without germline CDKN2A mutations 131
PTCH1 germline mutations and the basaloid follicular hamartoma values in the tumor spectrum of basal cell carcinoma syndrome (NBCCS) 130
Analysis of Cultured Human Melanocytes Based on Polymorphisms within the SLC45A2/MATP, SLC24A5/NCKX5, and OCA2/P Loci. 130
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 129
MC1R variants as melanoma risk factors independent of at-risk phenotypic characteristics: A pooled analysis from the M-SKIP project 129
INK4/ARF germline alterations in pancreatic cancer patients 129
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin 128
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 128
Absence of melanocortin 1 receptor variants in Ligurian Gly101trp families 127
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 127
CDKN2A mutation distribution in ligurian sporadic melanoma according to age at diagnosis 125
Analisi della sequenza codificante e regolatrice del gene di suscettibilità al melanoma CDKN2A in 62 famiglie 125
Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome. 122
Correlation between NF-kB/GM-CSF expression and functional status of the p16 melanoma susceptibility gene 122
Analisi di mutazioni del gene PTCH nella sindrome di Gorlin 121
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort 119
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 117
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting 115
Correlazione tra l’espressione di NF-KB e lo stato funzionale del gene di suscettibilità al melanoma familiare CDKN2A (p16ink4) 112
MC1R gene variants and non-melanoma skin cancer: A pooled-analysis from the M-SKIP project 112
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 110
Varianti polimorfiche del gene MC1R (melanocortin receptor 1): Analisi in pazienti Liguri affetti da melanoma e negativi per mutazioni nei geni CDKN2A e CDK4 109
Diagnostic and pathogenetic role of cafe-au-lait macules in nevoid basal cell carcinoma syndrome 109
Frequency of 3’UTR polymorphisms in the CDKN2A gene in familial and non-familial Ligurian melanoma patients 108
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the melanoma-pancreatic cancer syndrome in Italy 107
Clinical utility gene card for: Gorlin syndrome 107
Erratum: A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma (Nature (2011) 480:94-98 doi:10.1038/nature10539) 104
Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma 104
Proteomic analysis of PTCH1 +/- Fibroblast lysate and conditioned culture media isolated from the skin of healthy subjects and nevoid basal cell carcinoma syndrome patients 101
Insights into mechanisms of tumorigenesis in neuroendocrine neoplasms 100
INK4/ARF germline mutations and additional neoplasia in pancreatic cancer patients and their families 98
Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: Sphenoid asymmetry in a patient with a novel PTCH1 mutation 97
Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants 96
Totale 15.481
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.470
article - articoli 48.551
book - libri 0
conference - conferenze 8.577
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 342
Totale 114.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.312 30 103 83 178 53 85 94 308 70 111 50 147
2022/20231.399 154 117 11 156 260 193 10 97 201 12 167 21
2023/2024823 27 95 9 94 47 132 50 56 71 38 54 150
2024/20252.409 95 165 81 184 276 235 256 441 91 101 202 282
2025/20264.706 527 159 527 388 533 385 614 189 364 406 330 284
2026/2027419 419 0 0 0 0 0 0 0 0 0 0 0
Totale 17.160